- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Dixie L. Johnson
News 40 results
In the News · Source: Law360, The Deal, Hotel Business and The American Lawyer
December 2, 2021
K&S advises BOA Acquisition on its $1.2B acquisition of Selina
Cases & Deals
December 2, 2021
BOA Acquisition Corp. to Merge with Selina in de-SPAC Transaction
In the News · Source: Daily Report
Recognition
November 10, 2021
GIR Names King & Spalding to List of Top 30 Global Investigations Firms for Seventh Year
Events 15 results
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
November 2, 2021
Craig Carpenito, Dixie Johnson, Nikki Reeves, Seth Lundy to Speak at Virtual 22nd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress
Speaking Engagement
January 25, 2021
Dixie Johnson, Richard Walker to Speak on 2021 Securities Regulation Institute’s Virtual Conference
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Insights 35 results
Client Alert
December 20, 2021
Reviving the Holiday Gathering This Year? Avoid Adding Insider Trading Liability to the Mix.
Client Alert
September 28, 2021
SEC Enforcement of Human Capital Disclosures: The First Fingerprints
Feature
February 10, 2021
General Counsel Internal Investigations Decision Tree for the Automotive Industry
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry